Vasopressin acts on platelets to generate procoagulant activity

Blood Coagulation and Fibrinolysis

Volumn 19, Issue 7, 2008, Pages 615-624

  Tomasiak, Marian ^a   Stelmach, Halina ^a   Rusak, Tomasz ^a   Ciborowski, Michał ^a   Radziwon, Piotr ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Na+ H+ exchanger; Platelet volume; Platelets; Procoagulant activity; Vasopressin

Indexed keywords

5 (N ETHYL N ISOPROPYL)AMILORIDE; ARGIPRESSIN; COLLAGEN; GENISTEIN; MONENSIN; PHOSPHATIDYLSERINE; SODIUM PROTON EXCHANGE PROTEIN;

ARTICLE; BLOOD CLOTTING; CALCIUM SIGNALING; CELL MEMBRANE; CELL POPULATION; COLLAGEN SYNTHESIS; FLOW CYTOMETRY; HORMONE ACTION; HUMAN; HUMAN CELL; MEMBRANE STRUCTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SODIUM TRANSPORT; THROMBOCYTE; THROMBOCYTE AGGREGATION; THROMBOCYTE VOLUME;

AMILORIDE; ARGININE VASOPRESSIN; BLOOD COAGULATION; BLOOD PLATELETS; CALCIUM SIGNALING; FLOW CYTOMETRY; GENISTEIN; HUMANS; PHOSPHATIDYLSERINES; PLATELET ACTIVATION; PLATELET AGGREGATION; PLATELET COUNT; SODIUM COMPOUNDS; SODIUM-HYDROGEN ANTIPORTER;

EID: 55049100011     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e328309905d     Document Type: Article

References (41)

1. Holmes CL, Patel BM, Russel JA, Walley KR. Physiology of vasopressin relevant to management of septic shock. Chest 2001; 120:989-1002.
2. Dyke PC. Vasopressin: applications in clinical practice. J Intensive Care Med 2004; 19:220-228.
3. Wun T, Paglieroni T, Lachant NA. Physiologic concentrations of arginine vasopressin activate human platelets in vitro. Br J Haematol 1996; 92:968-972.
4. Inaba K, Umeda Y, Yamane Y, Urakami M, Inada M. Characterization of human platelet vasopressin receptor and the relation between vasopressin-induced platelet aggregation and vasopressin binding to platelets. Clin Endocrinol 1998; 29:377-386.
5. 2+ increase in human platelets. Clin Physiol 1999; 19:305-310.
6. + exchanger in human platelets. Differential effect of phorbol ester and vasopressin. J Biol Chem 1996; 271:16494-16499.
7. + exchange is required for platelet aggregation induced by AVP (arginine-vasopressin). Thromb Res 1989; 5:89-393.
8. + exchangers of mammalian cells. J Biol Chem 1997; 272:22373-22376.
9. + antiporter. Cell 1989; 56:271-280.
10. Livine AA, Sardet C, Pouysségur J. The Na+/H+ exchanger is phosphorylated in human platelets in response to activating agents. FEBS Lett 1991; 284:219-222.
11. Rosskopf D. Sodium-hydrogen exchange and platelet function. J Thromb Thrombolys 1999; 8:15-23.
12. Stelmach H, Rusak T, Tomasiak M. The involvement of the Na+/H+ exchanger in the formation of microvesicles by porcine platelets. Haematologia 2002; 32:239-252.
13. Samson J, Stelmach H, Tomasiak M. The importance of Na+/H+ exchanger for the generation of procoagulant activity by porcine blood platelets. Platelets 2001; 12:436-442.
14. Horstman LL, Valle-Riestra BJ, Jy W, Wang F, Mao W, Ahn Y. Desmopressin (DDAVP) acts on platelets to generate platelet microparticles and enhanced procoagulant activity. Thromb Res 1995; 79:163-174.
15. Holmes CL, Landry DW, Granton JT. Science review: vasopressin and the cardiovascular system part 2 - clinical physiology. Crit Care 2004; 8:15-23.
16. Aung K, Htay T. Vasopressin for cardiac arrest: a systematic review and meta-analysis. Arch Intern Med 2005; 165:17-24.
17. Wenzel V, Krismer AC, Arntz HR, Sitter H, Stadlbauer KH, Lindner KH. A comparison of vasopressin and epinephrine for out-of-hospital cardiopulmonary resuscitation. N Engl J Med 2004; 350:105-113.
18. Rota S, Flynn PD, Wareham NJ, Baglin TP. Is platelet phospholipid- dependent thrombin generation altered by acute myocardial infarction or aspirin? Thromb Res 1996; 83:329-338.
19. Marsh NA. Use of snake venom fractions in the coagulation laboratory. Blood Coagul Fibrinolysis 1998; 9:395-404.
20. + exchange in platelets of patients with essential hypertension using an optical swelling assay. J Hypertens 1991; 9:231-238.
21. Bednar RA, Gaul SL, Hamill TG, Egbertson MS, Shafer JA. Identification of low molecular weight GP IIb/IIIa antagonists that bind preferentially to activated platelets. J Pharmacol Exp Ther 1998; 285:1317-1326.
22. Born GV, Cross MJ. The aggregation of blood platelets. J Physiol 1963; 168:178-195.
23. Telejko B, Tomasiak M, Stelmach H, Kinalska I. Platelet sodium-proton exchanger and phospholipid-dependent procoagulant activity in patients with type 2 diabetes. Metabolism 2003; 52:102-106.
24. Mollenhauer HH, Morre DJ, Rowe LD. Alteration of intracellular traffic by monensin; mechanism specificity and relationship to toxicity. Biochim Biophys Acta 1990; 1031:225-246.
25. Bode AP, Hickerson DHM. Characterization and quantitation by flow cytometry of membranous microparticles formed during activation of platelet suspensions with ionophore or thrombin. Platelets 2000; 11:259-271.
26. Wolfs JL, Comfurius P, Rasmussen JT, Keuren JF, Lindhout T, Zwaal RF, Bevers EM. Activated scramblase and inhibited aminophospholipid translocase cause phosphatidylserine exposure in a distinct platelet fraction. Cell Mol Life Sci 2005; 62:1514-1525.
27. Zwaal RFA, Schroit AJ. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 1997; 4:1121-1132.
28. Sims PJ, Wiedmer T. Unraveling the mysteries of phospholipid scrambling. Thromb Haemost 2001; 86:266-275.
29. Heemskerk J, Bevers E, Lindhout T. Platelet activation and blood coagulation. Thromb Haemost 2002; 88:186-193.
30. Bevers EM, Comfurius P, Deekkers DW, Zwaal R. Lipid translocation across the plasma membrane of mammalian cells. Biochim Biophys Acta 1999; 1439:317-330.
31. Courageot MP, Lepine S, Hours M, Giraud F, Sulpice JC. Involvement of sodium in early phosphatidylserine exposure and phospholipid scrambling induced by P2X7 purinoceptor activation in thymocytes. J Biol Chem 2004; 279:21815-21823.
32. Winnicka K, Stelmach H, Rusak T, Tomasiak M. The in vitro effect of proscillaridin on platelet responses. Acta Pol Pharm 2005; 62:319-325.
33. Lang F, Busch GL, Ritter M, Völkl H, Waldegger S, Gulbins E, Häussinger D. Functional significance of cell volume regulatory mechanisms. Physiol Rev 1998; 78:247-306.
34. Straub SG, Daniel S, Sharp GWG. Hyposmotic shock stimulates insulin secretion by two distinct mechanisms. Studies with the betaHC9 cell. Am J Physiol Endocrinol Metab 2002; 282:E1070-E1076.
35. + exchanger in serotonin secretion from porcine blood platelets. Acta Biochim Polon 2005; 52:811-822.
36. Reed G, Fitzgerald M, Polgar J. Molecular mechanisms of platelet exocytosis: insights into the 'secrete' life of thrombocytes. Blood 2000; 15:3334-3342.
37. Flaumenhaft R. Molecular basis of platelet granule secretion. Arterioscler Thromb Vasc Biol 2003; 23:1152-1160.
38. Fritz M, Radmacher M, Gauub HE. Granula motion and membrane spreading during activation of human platelets imaged by atomic force microscopy. Biophys J 1994; 66:1328-1334.
39. Shi J, Heegaard CW, Rasmussen JT, Gilbert GE. Lactadherin binds selectively to membranes containing phosphatidyl-L-serine and increased curvature. Biochim Biophys Acta 2004; 1667:82-90.
40. Dunser MW, Mayr AJ, Ulmer H, Ritsch N, Knotzer H, Pajk W, et al. The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and postcardiotomy shock: a retrospective analysis. Anesth Analg 2001; 93:7-13.
41. Luckner G, Dunser MW, Jochberger S, Mayr VD, Wenzel V, Ulmer H, et al. Arginine vasopressin in 316 patients with advanced vasodilatory shock. Crit Care Med 2005; 33:2659-2666.